The Association of Racing Commissioners International's (RCI) Board of Directors has unanimously approved a drug reclassification of stanozolol, boldenone, nandrolone, and testosterone, moving the anabolic steroids to Class 3 from Class 4.

This change in classification clears the way for racing commissions to impose tougher penalties for a positive test consistent with the Model Rules or their individual jurisdictional practices.

"This move is consistent with the fact that the racing commissions believed the existing classification of a positive for these steroids was not sufficiently serious based upon the unanimous opinion of the Drug Testing Standards and Practices Committee as well as the majority recommendation of the Veterinary Pharmacology Subcommittee," RCI President Ed Martin said in a statement.

For full information on RCI's new drug and steroid classifications, click here.

(RCI)